Isodiol International, Inc. Enters Golf Market Through its Subsidiary Iso-Sport and Appoints Golf Professional Trent Gray as Channel Manager

- December 3rd, 2018

Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) the “Company” or “Isodiol” is pleased to announce the appointment of Mr. Trent Gray as channel manager of the Iso-SportGolf Division.

Isodiol International Inc. (CSE: ISOL) (OTCQB: ISOLF) (FSE: LB6B.F) the “Company” or “Isodiol” is pleased to announce the appointment of Mr. Trent Gray as channel manager of the Iso-SportGolf Division.

With an undeniable passion for golf spanning nearly four decades, Gray’s experience in the sport from the fairway to the clubhouse is impressive. He was introduced to golf at the age of 8 and began playing and winning local club tournaments and junior championships just a few short years later.

He would go on to compete at a high level in district and state tournaments throughout his youth. Before his first year of college was over, Gray was offered his first official job in golf as an Assistant Golf Professional. This began a career in the industry with jobs ranging from Tournament Director to Head Golf Professional.

Between managing the day-to-day activities of a golf course and its pro shop, Gray became proficient at technical project management while building business relationships. He uses his technical skills to provide real results and positively influence the marketplace.

Currently, Trent competes on the Golf Channel Am Tour where he has posted several impressive finishes in tournaments, including winning multiple times. He also enjoys promoting the game every chance he gets through junior clinics and tournaments.

Gray has embraced the opportunity to work with Iso-Sport: “To be able to effectively market the benefits of CBD performance products to golfers and develop meaningful relationships is something I’m definitely looking forward to,” he said.

“We’re thrilled to add Trent Gray to our team. He possesses a wealth of knowledge about the golf industry and his lifelong experience in the sport is very impressive,” said Isodiol CEO, Marcos Agramont. “We believe his unique skill set will provide added value to the division as we continue to seek new opportunities while growing our footprint within various sports markets,” added Agramont.

About Isodiol International Inc.

Isodiol International Inc. is focused on the development of CBD-based pharmaceuticals and CBD consumer products. With a dedicated passion for the industry it serves, the company’s mission is to create a cultural movement by building awareness and social acceptance, ultimately empowering people to live better lives – globally. This mission is enacted through unique divisions and subsidiaries that help deliver the powerful benefits of CBD to people around the world.

Since its inception, Isodiol® has directed its efforts toward advancing CBD research, education, development, and manufacturing. The company has made tremendous strides in the CBD space through clinical research and forging valuable partnerships that have allowed the manufacturing of goods in accordance with strict industry practices and standards.

BSPG Laboratories™, a subsidiary of Isodiol®, was recently registered with the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) for producing CBD as an active pharmaceutical ingredient (API) for use in pharmaceutical applications for humans and animals.

Isodiol® is a publicly-traded entity with corporate offices based in Vancouver, Canada, and additional operations in the United States, South America, and the U.K. For more information about Isodiol®, please visit https://isodiol.com or call (855) 979-6751.

Join Us On Facebook: https://www.facebook.com/IsodiolInternationalInc/
Twitter: @Isodiolintlinc

ON BEHALF OF THE BOARD
Marcos Agramont, CEO & Director

INVESTOR RELATIONS:
Ir@isodiol.com
604-409-4409

MEDIA CONTACT:
Christopher Hussey
media@isodiol.com

Forward-Looking Information: This news release contains “forward-looking information” within the meaning of applicable securities laws relating to statements regarding the Company’s business, products and future the Company’s business, its product offerings and plans for sales and marketing. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking information. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risks that the Company’s products and plan will vary from those stated in this news release and the Company may not be able to carry out its business plans as expected. Except as required by law, the Company expressly disclaims any obligation and does not intend, to update any forward-looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales reported. The statements in this news release are made as of the date of this release.

The CSE has not reviewed, approved or disapproved the content of this press release.

Click here to connect with Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) for an Investor Presentation. 

Get the latest Biotech Investing stock information

Get the latest information about companies associated with Biotech Investing Delivered directly to your inbox.

Biotech Investing

Select All
Select None

By selecting company or companies above, you are giving consent to receive email from those companies. And remember you can unsubscribe at any time

Leave a Reply

Your email address will not be published. Required fields are marked *